Prognostic factors for diffuse large B-cell lymphoma: clinical and biological factors in the rituximab era

被引：2
|
作者：
Liang, Xiping [1 ]
Hu, Renzhi [1 ]
Li, Qiying [1 ]
Wang, Chaoyu [1 ]
Liu, Yao [1 ]
机构：
[1] Chongqing Univ, Dept Hematol Oncol, Canc Hosp, Chongqing Key Lab Translat Res Canc Metastasis & I, Chongqing, Peoples R China
来源：
EXPERIMENTAL HEMATOLOGY | 2023年 / 122卷
关键词：
NCCN-IPI; EXPRESSION; CLASSIFICATION; BIOMARKER; SURVIVAL; ACCURATE; SUBTYPES; MARKER; DNA;
D O I：
10.1016/j.exphem.2023.03.003
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：1 / 9
页数：9
相关论文
共 50 条
  • [21] Prognostic factors and clinical survival outcome in patients with primary mediastinal diffuse large B-cell lymphoma in rituximab era: A population-based study
    Hang, Haifang
    Zhou, Hui
    Ma, Liyuan
    MEDICINE, 2024, 103 (08) : E37238
  • [22] PROPOSAL OF NEW PROGNOSTIC INDEX FOR PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA IN THE RITUXIMAB ERA
    Yoon, S.
    Yoon, D. H.
    Kim, S.
    Lee, K.
    Kang, E. H.
    Lee, S. W.
    Park, C. J.
    Park, C. S.
    Huh, J.
    Suh, C.
    HAEMATOLOGICA, 2015, 100 : 403 - 404
  • [23] Proposal of New Prognostic Index for Patients with Diffuse Large B-Cell Lymphoma in the Rituximab Era
    Yoon, Shinkyo
    Yoon, Dok Hyun
    Kim, Shin
    Lee, Kyoungmin
    Kang, Eun Hee
    Lee, Sang-wook
    Park, Chan-Jeoung
    Park, Chan-Sik
    Huh, Jooryung
    Suh, Cheolwon
    BLOOD, 2014, 124 (21)
  • [24] Outcomes of Cardiac Diffuse Large B-Cell Lymphoma in the Rituximab Era
    Al-Juhaishi, Taha
    Abu Zeinah, Ghaith
    Al-Kindi, Sadeer
    BLOOD, 2020, 136
  • [25] Primary breast diffuse large B-cell lymphoma in the era of rituximab
    Zhang, Na
    Cao, Caineng
    Zhu, Yuan
    Liu, Peng
    Liu, Luying
    Lu, Ke
    Luo, Jialin
    Zhou, Ning
    ONCOTARGETS AND THERAPY, 2016, 9 : 6093 - 6097
  • [26] Clinical features, survival and prognostic factors of primary testicular diffuse large B-cell lymphoma
    Bo Jia
    Yuankai Shi
    Mei Dong
    Fengyi Feng
    Sheng Yang
    Hua Lin
    Liqiang Zhou
    Shengyu Zhou
    Shanshan Chen
    Jianliang Yang
    Peng Liu
    Yan Qin
    Changgong Zhang
    Lin Gui
    Lin Wang
    Xue Wang
    Xiaohui He
    ChineseJournalofCancerResearch, 2014, 26 (04) : 459 - 465
  • [27] Clinical and prognostic factors guiding diagnosis and treatment of prostate diffuse large B-cell lymphoma
    Yirui Wei
    Weifeng He
    Dawei Xie
    Pushen Yang
    Hao Wang
    Jun Lu
    Xiaolong Liang
    Jianwen Wang
    Scientific Reports, 15 (1)
  • [28] Clinical features, survival and prognostic factors of primary testicular diffuse large B-cell lymphoma
    Jia, Bo
    Shi, Yuankai
    Dong, Mei
    Feng, Fengyi
    Yang, Sheng
    Lin, Hua
    Zhou, Liqiang
    Zhou, Shengyu
    Chen, Shanshan
    Yang, Jianliang
    Liu, Peng
    Qin, Yan
    Zhang, Changgong
    Gui, Lin
    Wang, Lin
    Wang, Xue
    He, Xiaohui
    CHINESE JOURNAL OF CANCER RESEARCH, 2014, 26 (04) : 459 - 465
  • [29] Molecular and Immunophenotypic Prognostic Factors of Diffuse Large B-cell Lymphoma in Malawi
    Fedoriw, Yuri
    Montgomery, Nathan
    Selitsky, Sara
    Tomoka, Tamiwe
    Dhungel, Bal
    Mulenga, Maurice L.
    Parker, Joel
    Gopal, Satish
    LABORATORY INVESTIGATION, 2018, 98 : 515 - 515
  • [30] Molecular and Immunophenotypic Prognostic Factors of Diffuse Large B-cell Lymphoma in Malawi
    Fedoriw, Yuri
    Montgomery, Nathan
    Selitsky, Sara
    Tomoka, Tamiwe
    Dhungel, Bal
    Mulenga, Maurice L.
    Parker, Joel
    Gopal, Satish
    MODERN PATHOLOGY, 2018, 31 : 515 - 515
12345